Medical - Devices
Compare Stocks
5 / 10Stock Comparison
INGN vs LNTH vs CRVL vs APOG vs PHM
Revenue, margins, valuation, and 5-year total return — side by side.
Drug Manufacturers - Specialty & Generic
Insurance - Brokers
Construction
Residential Construction
INGN vs LNTH vs CRVL vs APOG vs PHM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Devices | Drug Manufacturers - Specialty & Generic | Insurance - Brokers | Construction | Residential Construction |
| Market Cap | $196M | $5.92B | $2.98B | $787M | $22.46B |
| Revenue (TTM) | $351M | $1.55B | $941M | $1.40B | $16.83B |
| Net Income (TTM) | $-25M | $279M | $106M | $54M | $2.04B |
| Gross Margin | 47.6% | 60.5% | 24.2% | 22.7% | 26.1% |
| Operating Margin | -9.1% | 18.8% | 14.5% | 6.7% | 16.4% |
| Forward P/E | — | 17.5x | 33.4x | 10.6x | 11.7x |
| Total Debt | $17M | $738K | $28M | $286M | $2.40B |
| Cash & Equiv. | $104M | $359M | $171M | $40M | $2.01B |
INGN vs LNTH vs CRVL vs APOG vs PHM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Inogen, Inc. (INGN) | 100 | 18.9 | -81.1% |
| Lantheus Holdings, … (LNTH) | 100 | 662.8 | +562.8% |
| CorVel Corporation (CRVL) | 100 | 256.6 | +156.6% |
| Apogee Enterprises,… (APOG) | 100 | 177.1 | +77.1% |
| PulteGroup, Inc. (PHM) | 100 | 344.1 | +244.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: INGN vs LNTH vs CRVL vs APOG vs PHM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, INGN doesn't own a clear edge in any measured category.
LNTH has the current edge in this matchup, primarily because of its strength in long-term compounding and sleep-well-at-night.
- 41.9% 10Y total return vs PHM's 5.7%
- Lower volatility, beta 0.47, Low D/E 0.1%, current ratio 2.70x
- 18.0% margin vs INGN's -7.1%
- Beta 0.47 vs APOG's 1.25, lower leverage
CRVL is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 12.6%, EPS growth 24.5%, 3Y rev CAGR 11.5%
- 12.6% revenue growth vs PHM's -3.5%
- 16.4% ROA vs INGN's -8.3%, ROIC 51.3% vs -24.4%
APOG ranks third and is worth considering specifically for income & stability and valuation efficiency.
- Dividend streak 14 yrs, beta 1.25, yield 2.8%
- PEG 0.32 vs PHM's 0.71
- Lower P/E (10.6x vs 11.7x), PEG 0.32 vs 0.71
- 2.8% yield, 14-year raise streak, vs PHM's 0.8%, (3 stocks pay no dividend)
PHM is the clearest fit if your priority is defensive.
- Beta 1.01, yield 0.8%, current ratio 5.91x
- +16.3% vs CRVL's -47.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.6% revenue growth vs PHM's -3.5% | |
| Value | Lower P/E (10.6x vs 11.7x), PEG 0.32 vs 0.71 | |
| Quality / Margins | 18.0% margin vs INGN's -7.1% | |
| Stability / Safety | Beta 0.47 vs APOG's 1.25, lower leverage | |
| Dividends | 2.8% yield, 14-year raise streak, vs PHM's 0.8%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +16.3% vs CRVL's -47.9% | |
| Efficiency (ROA) | 16.4% ROA vs INGN's -8.3%, ROIC 51.3% vs -24.4% |
INGN vs LNTH vs CRVL vs APOG vs PHM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
INGN vs LNTH vs CRVL vs APOG vs PHM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
LNTH leads in 2 of 6 categories
APOG leads 2 • CRVL leads 1 • INGN leads 0 • PHM leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
LNTH leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PHM is the larger business by revenue, generating $16.8B annually — 47.9x INGN's $351M. LNTH is the more profitable business, keeping 18.0% of every revenue dollar as net income compared to INGN's -7.1%. On growth, INGN holds the edge at +3.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $351M | $1.5B | $941M | $1.4B | $16.8B |
| EBITDAEarnings before interest/tax | -$16M | $347M | $168M | $57M | $2.8B |
| Net IncomeAfter-tax profit | -$25M | $279M | $106M | $54M | $2.0B |
| Free Cash FlowCash after capex | -$9M | $372M | $69M | $95M | $1.6B |
| Gross MarginGross profit ÷ Revenue | +47.6% | +60.5% | +24.2% | +22.7% | +26.1% |
| Operating MarginEBIT ÷ Revenue | -9.1% | +18.8% | +14.5% | +6.7% | +16.4% |
| Net MarginNet income ÷ Revenue | -7.1% | +18.0% | +11.2% | +3.9% | +12.1% |
| FCF MarginFCF ÷ Revenue | -2.6% | +24.0% | +7.3% | +6.8% | +9.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.4% | +1.2% | +3.4% | +1.6% | -12.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -20.0% | +76.5% | +2.2% | +6.1% | -30.4% |
Valuation Metrics
APOG leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 10.5x trailing earnings, PHM trades at a 67% valuation discount to CRVL's 31.7x P/E. Adjusting for growth (PEG ratio), APOG offers better value at 0.43x vs PHM's 0.64x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $196M | $5.9B | $3.0B | $787M | $22.5B |
| Enterprise ValueMkt cap + debt − cash | $110M | $5.6B | $2.8B | $1.0B | $22.9B |
| Trailing P/EPrice ÷ TTM EPS | -8.46x | 26.69x | 31.73x | 14.52x | 10.51x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 17.52x | 33.37x | 10.64x | 11.68x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.43x | 0.64x |
| EV / EBITDAEnterprise value multiple | — | 14.61x | 18.88x | 21.95x | 7.35x |
| Price / SalesMarket cap ÷ Revenue | 0.56x | 3.84x | 3.33x | 0.56x | 1.30x |
| Price / BookPrice ÷ Book value/share | 1.02x | 5.72x | 9.38x | 1.53x | 1.80x |
| Price / FCFMarket cap ÷ FCF | — | 16.73x | 32.57x | 8.27x | 12.84x |
Profitability & Efficiency
CRVL leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
CRVL delivers a 28.1% return on equity — every $100 of shareholder capital generates $28 in annual profit, vs $-13 for INGN. LNTH carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to APOG's 0.56x. On the Piotroski fundamental quality scale (0–9), CRVL scores 8/9 vs PHM's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -12.9% | +24.3% | +28.1% | +10.8% | +15.9% |
| ROA (TTM)Return on assets | -8.3% | +12.4% | +16.4% | +4.8% | +11.4% |
| ROICReturn on invested capital | -24.4% | +30.6% | +51.3% | +8.1% | +17.2% |
| ROCEReturn on capital employed | -13.3% | +17.1% | +39.5% | +9.7% | +20.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 8 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.09x | 0.00x | 0.09x | 0.56x | 0.19x |
| Net DebtTotal debt minus cash | -$86M | -$358M | -$143M | $247M | $394M |
| Cash & Equiv.Liquid assets | $104M | $359M | $171M | $40M | $2.0B |
| Total DebtShort + long-term debt | $17M | $738,000 | $28M | $286M | $2.4B |
| Interest CoverageEBIT ÷ Interest expense | — | 11.72x | — | 5.97x | 5590.17x |
Total Returns (Dividends Reinvested)
Evenly matched — LNTH and PHM each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LNTH five years ago would be worth $41,420 today (with dividends reinvested), compared to $1,079 for INGN. Over the past 12 months, PHM leads with a +16.3% total return vs CRVL's -47.9%. The 3-year compound annual growth rate (CAGR) favors PHM at 20.8% vs INGN's -15.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +8.4% | +35.3% | -11.7% | -1.3% | -1.6% |
| 1-Year ReturnPast 12 months | +0.3% | +13.1% | -47.9% | -2.8% | +16.3% |
| 3-Year ReturnCumulative with dividends | -39.3% | -4.0% | -16.7% | -0.1% | +76.2% |
| 5-Year ReturnCumulative with dividends | -89.2% | +314.2% | +45.7% | +12.9% | +95.4% |
| 10-Year ReturnCumulative with dividends | -85.3% | +4192.5% | +267.5% | +10.5% | +571.2% |
| CAGR (3Y)Annualised 3-year return | -15.3% | -1.4% | -5.9% | -0.0% | +20.8% |
Risk & Volatility
LNTH leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
LNTH is the less volatile stock with a 0.47 beta — it tends to amplify market swings less than APOG's 1.25 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LNTH currently trades 97.8% from its 52-week high vs CRVL's 49.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.10x | 0.47x | 0.48x | 1.25x | 1.01x |
| 52-Week HighHighest price in past year | $9.13 | $93.00 | $117.22 | $49.99 | $144.27 |
| 52-Week LowLowest price in past year | $5.34 | $47.25 | $44.83 | $30.75 | $95.20 |
| % of 52W HighCurrent price vs 52-week peak | +78.8% | +97.8% | +49.5% | +73.2% | +81.0% |
| RSI (14)Momentum oscillator 0–100 | 58.7 | 61.2 | 46.5 | 53.6 | 46.5 |
| Avg Volume (50D)Average daily shares traded | 282K | 886K | 203K | 253K | 1.7M |
Analyst Outlook
APOG leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: INGN as "Buy", LNTH as "Buy", APOG as "Hold", PHM as "Hold". Consensus price targets imply 261.6% upside for INGN (target: $26) vs 11.0% for LNTH (target: $101). For income investors, APOG offers the higher dividend yield at 2.83% vs PHM's 0.76%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | — | Hold | Hold |
| Price TargetConsensus 12-month target | $26.00 | $101.00 | — | $70.50 | $141.22 |
| # AnalystsCovering analysts | 11 | 17 | — | 6 | 44 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +2.8% | +0.8% |
| Dividend StreakConsecutive years of raises | — | 0 | 1 | 14 | 7 |
| Dividend / ShareAnnual DPS | — | — | — | $1.04 | $0.89 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +5.1% | +1.3% | +1.9% | +5.5% |
LNTH leads in 2 of 6 categories (Income & Cash Flow, Risk & Volatility). APOG leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.
INGN vs LNTH vs CRVL vs APOG vs PHM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is INGN or LNTH or CRVL or APOG or PHM a better buy right now?
For growth investors, CorVel Corporation (CRVL) is the stronger pick with 12.
6% revenue growth year-over-year, versus -3. 5% for PulteGroup, Inc. (PHM). PulteGroup, Inc. (PHM) offers the better valuation at 10. 5x trailing P/E (11. 7x forward), making it the more compelling value choice. Analysts rate Inogen, Inc. (INGN) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — INGN or LNTH or CRVL or APOG or PHM?
On trailing P/E, PulteGroup, Inc.
(PHM) is the cheapest at 10. 5x versus CorVel Corporation at 31. 7x. On forward P/E, Apogee Enterprises, Inc. is actually cheaper at 10. 6x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Apogee Enterprises, Inc. wins at 0. 32x versus PulteGroup, Inc. 's 0. 71x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — INGN or LNTH or CRVL or APOG or PHM?
Over the past 5 years, Lantheus Holdings, Inc.
(LNTH) delivered a total return of +314. 2%, compared to -89. 2% for Inogen, Inc. (INGN). Over 10 years, the gap is even starker: LNTH returned +41. 9% versus INGN's -85. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — INGN or LNTH or CRVL or APOG or PHM?
By beta (market sensitivity over 5 years), Lantheus Holdings, Inc.
(LNTH) is the lower-risk stock at 0. 47β versus Apogee Enterprises, Inc. 's 1. 25β — meaning APOG is approximately 166% more volatile than LNTH relative to the S&P 500. On balance sheet safety, Lantheus Holdings, Inc. (LNTH) carries a lower debt/equity ratio of 0% versus 56% for Apogee Enterprises, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — INGN or LNTH or CRVL or APOG or PHM?
By revenue growth (latest reported year), CorVel Corporation (CRVL) is pulling ahead at 12.
6% versus -3. 5% for PulteGroup, Inc. (PHM). On earnings-per-share growth, the picture is similar: Inogen, Inc. grew EPS 44. 1% year-over-year, compared to -35. 2% for Apogee Enterprises, Inc.. Over a 3-year CAGR, LNTH leads at 18. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — INGN or LNTH or CRVL or APOG or PHM?
Lantheus Holdings, Inc.
(LNTH) is the more profitable company, earning 15. 2% net margin versus -6. 5% for Inogen, Inc. — meaning it keeps 15. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LNTH leads at 20. 2% versus -8. 7% for INGN. At the gross margin level — before operating expenses — LNTH leads at 61. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is INGN or LNTH or CRVL or APOG or PHM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Apogee Enterprises, Inc. (APOG) is the more undervalued stock at a PEG of 0. 32x versus PulteGroup, Inc. 's 0. 71x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Apogee Enterprises, Inc. (APOG) trades at 10. 6x forward P/E versus 33. 4x for CorVel Corporation — 22. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for INGN: 261. 6% to $26. 00.
08Which pays a better dividend — INGN or LNTH or CRVL or APOG or PHM?
In this comparison, APOG (2.
8% yield), PHM (0. 8% yield) pay a dividend. INGN, LNTH, CRVL do not pay a meaningful dividend and should not be held primarily for income.
09Is INGN or LNTH or CRVL or APOG or PHM better for a retirement portfolio?
For long-horizon retirement investors, PulteGroup, Inc.
(PHM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 01), 0. 8% yield, +571. 2% 10Y return). Both have compounded well over 10 years (PHM: +571. 2%, INGN: -85. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between INGN and LNTH and CRVL and APOG and PHM?
These companies operate in different sectors (INGN (Healthcare) and LNTH (Healthcare) and CRVL (Financial Services) and APOG (Industrials) and PHM (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: INGN is a small-cap quality compounder stock; LNTH is a small-cap quality compounder stock; CRVL is a small-cap quality compounder stock; APOG is a small-cap deep-value stock; PHM is a mid-cap deep-value stock. APOG, PHM pay a dividend while INGN, LNTH, CRVL do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.